April 19, 2013

The Consumer Healthcare Products Association’s Stop Medicine Abuse campaign was selected as an official honoree in the 17th Annual Webby Awards in the Family/Parenting category, the over-the-counter association announced.

March 22, 2013

Sens. Bob Casey, D-Pa., and Lisa Murkowski, R-Ark., on Friday introduced the Preventing Abuse of Cough Treatments Act of 2013, which would require retailers to restrict the sale of dextromethorphan-containing products to adults.

March 15, 2013

The OTC industry is well-positioned to seize opportunities across the self-care space, executives at the recent Consumer Healthcare Products Association Annual Executive Conference shared with attendees. Those opportunities will be driven by greater consumer engagement and the growing realization around how much healthcare value can be drawn from expanding OTC access.

That sets the stage for some pretty favorable growth across a $38.3 billion industry. According to an Edelman in Health survey, use of over-the-counter medicines is already prevalent among Americans — almost 85% of Americans reported regular use of an OTC remedy. Convenience, efficacy and value were three of the key factors behind that prevalence, as noted in a special report compiled by DSN.

January 23, 2013

The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association on Tuesday joined forces to honor the Bucks County, Pa.-based Bucks Promise for Youth and Communities with this year’s Dose of Prevention award.

December 27, 2012

The National Institute on Drug Abuse last week released the 2012 Monitoring the Future survey, finding that 5.6% of high school seniors, 3% of eighth graders and 4.7% of tenth graders abused over-the-counter cough and cold medicines containing dextromethorphan, bringing the overall average to under 5%.

October 10, 2012

AccuDial Pharmaceutical recently launched four products as part of its Go-Green pediatric liquid cough-cold lineup that features dosing information on a rotating label, a larger 6-point font and a dosing cup that's shrink-wrapped to the top of the container.

October 1, 2012

The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association are mobilizing communities to stop prescription and over-the-counter medicine abuse during National Medicine Abuse Awareness Month, the groups announced Monday.

August 28, 2012

Perrigo and Tris Pharma have launched a private-label version of Delsym extended-release oral liquid suspension containing dextromethorphan polistirex.

July 11, 2012

Sens. Bob Casey, D.-Pa., and Lisa Murkowski, R-Alaska, on Wednesday introduced bipartisan legislation to prevent the abuse of cough syrup to get high by restricting the sale of products containing dextromethorphan to adults older than 18 years of age.

June 8, 2012

Making a direct appeal to teens, the Consumer Healthcare Products Association has created the website DXMstories.org that directly engages young adults around the dangers of dextromethorphan abuse with provocative video clips featuring peer anecdotes.

May 31, 2012

Tris Pharma on Thursday announced that the Food and Drug Administration has approved its generic equivalent to Reckitt Benckiser's Delsym, an extended-release oral liquid suspension containing dextromethorphan.

January 3, 2012

Zarbee’s has been expanding its pediatric cough-cold line featuring buckwheat honey with the launch of Zarbee’s Nighttime Cough and Sleep Drink, an over-the-counter nighttime cough remedy proven safe and effective for children 2 years of age and older.


December 15, 2011

The Consumer Healthcare Products Association on Thursday identified Tammy Walsh as the newest mom to join its Five Moms campaign to raise awareness of teen cough medicine abuse among parents.

December 15, 2011

Approximately 5.3% of high school seniors abused over-the-counter cough-cold medicines in the past month, according to the latest "Monitoring the Future" survey released Wednesday by the National Institute on Drug Abuse.

December 7, 2011

The Consumer Healthcare Products Association, the Community Anti-Drug Coalitions of America and the Miami Coalition last week held a town hall meeting on preventing teen cough medicine abuse.

October 5, 2011

Zarbee's on Wednesday announced the launch of Zarbee's Nighttime Cough and Sleep Drink, an over-the-counter nighttime cough remedy.

September 26, 2011

The U.S. Senate last week adopted a resolution designating the month of October 2011 as “National Medicine Abuse Awareness Month” to raise attention to the problem of prescription medicine abuse, especially by teenagers.

September 1, 2011

California on Wednesday banned the sale of dextromethorphan to minors, becoming the first state to pass such legislation.

August 11, 2011

Drug maker Avanir Pharmaceuticals has filed suit against two generic drug makers seeking to launch versions of a drug used to treat pseudobulbar affect, which causes sudden, involuntary episodes of laughing and crying, and occurs secondary to numerous other neurological conditions.

March 28, 2011

The U.S. Pharmacopeial Convention last week announced that it is working with the Food and Drug Administration and the Consumer Healthcare Products Association to update quality standards for widely used medicines and ingredients. Updated test methodologies are crucial to help counter economically motivated adulteration — in which less expensive and potentially harmful ingredients are substituted for genuine medicines or their ingredients — and also to address the challenge of impurities that may go undetected with older, nonspecific assays and tests.

March 25, 2011

There are three issues involving over-the-counter medicines today that have put the industry on the defensive, and all involve the question of appropriate access. Drug Store News examined each.

1. FLEXIBLE SPENDING ACCOUNTS The issue: The Patient Protection and Affordable Care Act required that FSA participants obtain a prescription for those OTCs incorporated into their health savings agenda.

March 2, 2011

The Food and Drug Administration has taken action against makers of prescription drugs for cough-cold and allergies that don’t have regulatory approval, the agency said Wednesday.

February 10, 2011

Over-the-counter generic versions of a line of products used to treat congestion do not infringe on the patents covering the branded versions, a federal court ruled Wednesday.

October 10, 2010

While the fact that two Food and Drug Administration advisory committees collectively voted 15 opposed...